Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.

Share:
More In Business
Be Prepared for No Rate Cuts in 2024
With stubborn inflation sticking at about 2.8%, there’s a chance that the Fed won’t cut rates this year. That might be the smarter choice in the long run.
Load More